menu
    • menu

    Company profile for Solara Active Pharma Sciences

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer. We have a legacy of over three decades and trace our origins to the API expertise of Strides Shasun Ltd. and the technical know-how of human API business from Sequent Scientific Ltd. We are poised to bridge the industry gap by delivering value based products while maintaining focus on the customer needs. We have 140+ scie...
    Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer. We have a legacy of over three decades and trace our origins to the API expertise of Strides Shasun Ltd. and the technical know-how of human API business from Sequent Scientific Ltd. We are poised to bridge the industry gap by delivering value based products while maintaining focus on the customer needs. We have 140+ scientists working at our two R&D Centers and 4 API manufacturing facilities armed with global approvals and 2 dedicated R&D facilities.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Solara Active Pharma Sciencesindia-flag Flag
    Country
    Country
    India
    Address
    Address
    3rd & 4th Floor, Batra Centre, No.28, Sardar Patel Road, Guindy, Chennai – 6...
    Telephone
    Telephone
    +91 44 4344 6700
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://solara.co.in/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/solara-active-pharma-sciences
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    “Translational Pharmaceutics, our flagship platform for drug development, empowers our clients with unparalleled flexibility”

    “Translational Pharmaceutics, our flagship platform for drug development, empowers our clients with unparalleled flexibility”

    This week, SpeakPharma interviews Denise Sutton, Chief Operating Officer and Site Head at Quotient Sciences’ Nottingham facility in the UK. Quotient Sciences is a drug development and manufacturing accelerator that offers the innovative Translational Pharmaceutics platform to support customers in overcoming drug development challenges. Sutton has been with the company for over 25 years. In this interview, she provides insights into the evolution of Quotient Sciences’ Nottingham facility and discusses how the organization has transformed from a small 10-bed clinic to a comprehensive drug development campus with six GMP suites. She also shares her perspective on the company’s unique approach to integrating drug development services. HIGHLIGHTS// evolution of Quotient Sciences’ Nottingham facility/ unique approach to integrating drug development services How has the Nottingham site transformed from when it was founded, to what it is today? Initially, we were a small company with fewer than 50 employees, a 10-bed clinic, and a single lab. Over 90 percent of our work focused on gamma scintigraphic imaging (a diagnostic test that creates images of the body’s internal organs and tissues using gamma rays). Due to the short half-life radionuclides we used to label dosage forms, every product we manufactured had a limited time to be dosed. At the end of 1999, we moved our headquarters to a purpose-built, two-storey facility—now known as Trent House on our now much larger Nottingham campus. We built three good manufacturing practice (GMP) suites on the top floor and three clinical wards on the bottom floor. These were very early days that marked the start of our Translational Pharmaceutics platform. We continued to expand the range of scintigraphy applications we offered in response to changing customer requirements until, in 2008, when we approached the MHRA (UK’s Medicines and Healthcare products Regulatory Agency) with a new request. We asked if it might be possible to work at the same pace as we did in our scintigraphic imaging studies, but do so for conventional drug development, without the radiolabel. We explored the application of ICH Q8 Quality by Design (QbD) guidelines to introduce a compositional design space into the CMC section of our regulatory dossier. This officially created a methodology for applying the Translational Pharmaceutics platform, and we haven't looked back since. Today, we have expanded substantially. Our Nottingham site is a campus of five buildings. We have development and analytical labs, six GMP suites, six clinical wards with a total of 85 beds (where we conduct healthy volunteer phase 1 clinical studies), and many talented colleagues covering our spectrum of CRO and CDMO services. HIGHLIGHTS// officially created a methodology for applying the Translational Pharmaceutics platform/ development and analytical labs/ six GMP suites   How is Translational Pharmaceutics applied to drug development programs? We apply Translational Pharmaceutics across three core applications: first-in-human clinical studies, drug product optimization programs through rapid formulation development and clinical testing, and as a part of human ADME (absorption, distribution, metabolism, and excretion) programs. No matter how a client chooses to work with us to apply Translational Pharmaceutics, the benefits of using a single organization and project management team to integrate services lets our clients remain in control and one step ahead of the emerging data that impacts the success of their molecule. Over all these years, our flagship Translational Pharmaceutics platform for drug development has remained unchanged in the way it empowers our customers and offers them unparalleled flexibility. HIGHLIGHTS// three core applications/ benefits of using a single organization/ clients remain in control   What would you say are the key strengths of Quotient Sciences’ Nottingham site? How do you support customer programs? Nowhere else would a single project manager oversee such a broad spectrum of activities, let alone be expected to ensure seamless, timely progression across functions that in any other company (i.e. at other CDMOs or CROs) would be delivered through multiple operating areas or through the use of a combination of third-party vendors. The project managers do face challenges. But by working with the project team, they are able to anticipate, avoid, and mitigate any impact whenever necessary. We know that time is incredibly valuable for our customers. A project Gantt chart is our project management team’s guiding light. I believe our project management team is truly world-leading – they communicate well, show great compassion, and lead with integrity. I’m super proud of our high-performing, supportive, cross-functional teams that support our customers when they trust their molecules to us, and work collaboratively to deliver the best possible service. After 25 years at Quotient, I continue to really enjoy going to work. I am indebted to various colleagues for helping me continue to feel this way. HIGHLIGHTS// project management team is truly world-leading/ high-performing, supportive, cross-functional teams/ 25 years at Quotient  

    Impressions: 4566

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/translational-pharmaceutics-our-flagship-platform-for-drug-development-empowers-our-clients-with-unparalleled-flexibility

    Radio Compass
    16 Dec 2024
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    CDMO Activity Tracker: Bora, PolPharma make acquisitions; Evonik, EUROAPI, Porton announce technological expansions

    CDMO Activity Tracker: Bora, PolPharma make acquisitions; Evonik, EUROAPI, Porton announce technological expansions

    The contract development and manufacturing organization (CDMO) space continued to grow at an impressive pace in the second half (H2) of 2024, with significant progress being made across cell and gene therapies (CGTs), antibody-drug conjugates (ADCs), novel drug modalities, and digital solutions.Some of the key players in the CDMO space include Lonza, EUROAPI, Evonik, SEQENS, Fujifilm Diosynth Biotechnologies, Quotient Sciences, Axplora, PolPharma, and Famar from Europe; Mission CDMO, LGM Pharma, Veranova, and Thermo Fisher from the US; and Samsung Biologics, Bora Pharmaceuticals, and Porton Pharma Solutions from Asia. Texas-based Mission CDMO has been in the pharma industry for over 75 years. Today, it is known for its comprehensive contract services and high-quality manufacturing capabilities that have reinforced its position as a trusted partner. View CDMO Activity Tracker for H2 2024 (Free Excel Available)Bora, PolPharma drive CDMO acquisitions; Samsung Biologics clocks over US$ 4 bn in contract valueThe second half of 2024 saw several high-value acquisitions and expansions that reshaped the CDMO landscape. South Korea-based Samsung Biologics clocked a cumulative contract value of over US$ 4 billion. It signed its largest manufacturing deal with an Asia-based pharmaceutical company, valued at US$ 1.24 billion. It also announced a series of manufacturing deals with a European drugmaker worth over US$ 668 million. Samsung Biologics is also building a dedicated ADC facility that is likely to be complete soon. Taiwan’s largest CDMO, Bora Pharmaceuticals, announced its second acquisition of the year. It bought New Jersey-based Pyros Pharmaceuticals, a developer of rare disease treatments. Pyros recently launched Vigafyde, the only ready-to-use vigabatrin oral solution and the first new product approved to treat infantile spasms in 15 years. Bora also announced a strategic investment in Tanvex Biopharma, thereby creating a global platform for biologics development and supply.PolPharma acquired Ziołolek, a renowned manufacturer of dermatological products, medical devices, and OTC medicines, thereby expanding its product portfolio. It also launched a state-of-the-art HPAPI (highly potent active pharmaceutical ingredients) facility in Poland, which is being seen as another step towards securing Europe’s drug supply chain.In other developments, Avid Bioservices got acquired by funds managed by Ampersand and British healthcare investment firm GHO Capital Partners in an all-cash deal worth US$ 1.1 billion. And Agilent Technologies agreed to acquire Canadian specialty CDMO Biovectra for US$ 925 million, thereby enhancing its capabilities in gene-editing technologies and sterile fill-finish services. View CDMO Activity Tracker for H2 2024 (Free Excel Available) Evonik, EUROAPI, Porton Pharma, GSK announce tieups, technological expansionsSeveral CDMOs announced new collaborations and acquired new capabilities to enhance their service offerings. Evonik expanded its formulation capabilities for lipid nanoparticles used for mRNA and gene therapies through a collaboration with KNAUER Wissenschaftliche Geräte. This partnership aims to expand Evonik’s portfolio of biosolutions.Evonik is also restructuring its keto and pharma amino acid business to focus on strategic core growth areas. Evonik launched Eudracap colon functional capsules for targeted delivery of oral drugs. These ready-to-fill capsules are designed to release their contents specifically in the colon, improving the efficacy of treatments for various gastrointestinal conditions. Evonik also opened a new facility for drying aqueous dispersions of Eudragit polymers in Darmstadt, Germany. This facility will enhance Evonik’s capabilities in producing high-quality polymers for pharmaceutical applications.EUROAPI launched a new AI-powered Electronic Batch Record solution in collaboration with Aizon to enhance manufacturing productivity. This collaboration aims to digitize operations towards more data-driven manufacturing, focusing on small-scale productions and highly flexible plants.Porton Pharma Solutions has expanded its reach through several strategic initiatives. In October, Porton entered into a partnership with Shanghai InnoStar to enhance its service offerings beyond small molecules, targeting peptides, oligonucleotide drugs, conjugated drugs, and advanced therapies. It continued to grow its capabilities by enhancing its GMP manufacturing capacity in Fengxian, Shanghai (China). The facility’s expansion is aimed at increasing the production of novel therapies, including peptides and oligonucleotide drugs. These moves are part of Porton’s broader strategy to position itself at the forefront of advanced pharmaceutical manufacturing.Corden Pharma is investing € 900 million (US$ 985 million) over the next three years to expand its peptide platform facilities in Colorado (US) and Europe. While the US site will help meet the rising demand for GLP-1 peptides, in Europe, CordenPharma will construct a greenfield facility for small to large-scale peptide development and manufacturing.CDMO Touchlight signed a licensing agreement with GSK that grants the drug behemoth non-exclusive rights to use Touchlight’s proprietary enzymatic doggybone DNA (dbDNA) technology for the development and production of mRNA-based products, particularly vaccines. Curia also integrated enzymatic dbDNA solutions through a collaboration with Touchlight, enhancing mRNA production for vaccine and cancer therapies. View CDMO Activity Tracker for H2 2024 (Free Excel Available) Lonza, Merck, Dr. Reddy’s owned Aurigene invest in cell and gene therapiesThe CGT space continued to draw both deals and investments. Lonza and Vertex signed a long-term commercial supply agreement for Casgevy, the world’s first CRISPR/Cas9 gene-edited cell therapy, to treat sickle cell disease and beta thalassemia. This agreement includes manufacturing at Lonza’s Geleen (the Netherlands) cell therapy manufacturing facility, with plans to expand to Portsmouth, New Hampshire (US).Miltenyi Biotec began manufacturing lentiviral vectors for Adaptimmune’s Tecelra, the first engineered TCR T-cell therapy for the rare soft tissue cancer synovial sarcoma approved by the US Food and Drug Administration.Merck KGaA commenced commercial production at its first GMP-compliant manufacturing line for cell culture media (CCM) in China. This facility addresses the growing local demand for quality custom CCM used in biopharmaceuticals, vaccines, and novel therapeutics.Aurigene and Edity Therapeutics announced a strategic collaboration in cell therapy, with Aurigene providing cell therapy discovery services to support Edity’s clinical development. Additionally, Aurigene and its parent, Dr. Reddy’s Laboratories, signed a memorandum of understanding (MoU) with Kainomyx for the development and commercialization of an affordable anti-malarial drug. ProBio and UCI Therapeutics signed an MoU for a comprehensive collaboration in gene delivery technologies, including viral and non-viral approaches. Additionally, Korea’s VaxCell-Bio partnered with ProBio to accelerate the development of its chimeric antigen receptor (CAR)-related therapies.The ADC market continued to be a hotbed of innovation and strategic expansion. Merck KGaA invested € 70 million (US$ 75 million) to triple its ADC manufacturing capacity at its Missouri (US) facility, aiming to support the rising demand for oncology therapies.Sterling Pharma entered into a partnership with GlycoNex to support the clinical trials of their ADCs that target solid tumors. And, NJ Bio and Charles River Laboratories also announced a collaboration to optimize ADC manufacturing.The adeno-associated viral (AAV) vector field also saw activity with Rentschler Biopharma and Forge Biologics announcing the launch of a new service offering and a manufacturing platform, respectively. Similarly, Andelyn Biosciences was selected by Hubble Therapeutics to manufacture clinical grade AAV.Meanwhile, Lonza has gone in for a restructuring exercise in order to become a “pure-play CDMO”. It has exited its capsules and health ingredients business, and adopted a new organizational structure. The Swiss CDMO has also extended a collaboration with a major global biopharmaceutical partner for commercial-scale manufacture of ADCs. View CDMO Activity Tracker for H2 2024 (Free Excel Available) Our viewAs pharmaceutical development becomes increasingly complex, CDMOs are no longer just manufacturing partners, but critical innovation hubs. Little wonder then that 2024’s biggest pharma deal was in the CDMO space – Novo Holdings’ US$ 16.5 billion buyout of Catalent. This trend should gather momentum. We expect more M&A activity in this space in 2025. 
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 365

    https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-bora-polpharma-make-acquisitions-evonik-euroapi-porton-announce-technological-expansions

    #PharmaFlow by PHARMACOMPASS
    19 Dec 2024
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    Solara Active Pharma Reports Q2 FY25 Net Profit at Rs. 8.01 Cr
    Solara Active Pharma Reports Q2 FY25 Net Profit at Rs. 8.01 Cr

    23 Oct 2024

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/solara-active-pharma-sciences-reports-consolidated-q2-fy25-net-profit-at-rs-801-cr-16351

    INDPHARMAPOST
    23 Oct 2024
    Share Share
    Solara Active Pharma Sciences reports Q1 FY25 consolidated loss at Rs. 13.46 Cr
    Solara Active Pharma Sciences reports Q1 FY25 consolidated loss at Rs. 13.46 Cr

    23 Jul 2024

    // INDIANPHARMAPOST

    https://www.indianpharmapost.com/news/solara-active-pharma-sciences-reports-q1-fy25-consolidated-loss-at-rs-1346-cr-15903

    INDIANPHARMAPOST
    23 Jul 2024
    Share Share
    US FDA inspects Vishakhapatnam facility of Solara Active Pharma
    US FDA inspects Vishakhapatnam facility of Solara Active Pharma

    20 May 2024

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/us-fda-inspects-vishakhapatnam-facility-of-solara-active-pharma/articleshow/110264426.cms

    ECONOMICTIMES
    20 May 2024
    Share Share
    This pharma company gets approval to set up a new MFGfacility drug 'Ibuprofen'
    This pharma company gets approval to set up a new MFGfacility drug 'Ibuprofen'

    01 Nov 2022

    // Tushar Jain DSIJ

    https://www.dsij.in/dsijarticledetail/this-pharma-company-gets-approval-to-set-up-a-new-manufacturing-facility-for-its-popular-drug-ibuprofen-27086-1

    Tushar Jain DSIJ
    01 Nov 2022
    Share Share
    Solara Active Pharma slips 15% after Rajender Rao resigns as MD & CEO
    Solara Active Pharma slips 15% after Rajender Rao resigns as MD & CEO

    02 May 2022

    // BUSINESS STANDARD

    https://www.business-standard.com/article/markets/solara-active-pharma-slips-15-after-rajender-rao-resigns-as-md-ceo-122050200238_1.html#:~:text=Shares%20of%20Solara%20Active%20Pharma,effect%20from%20April%2028%2C%202022

    BUSINESS STANDARD
    02 May 2022
    Share Share
    Solara Active Pharma Sciences announces change in MD and CEO
    Solara Active Pharma Sciences announces change in MD and CEO

    28 Feb 2022

    // BUSINESS-STANDARD

    https://www.business-standard.com/article/news-cm/solara-active-pharma-sciences-announces-change-in-md-and-ceo-122022800492_1.html

    BUSINESS-STANDARD
    28 Feb 2022
    Share Share

    ALL APIs

    read-moreClick the button for full data set
    read-moreClick the button for full data set

    01

    Levetiracetam

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Antibody Engineering
    Not Confirmed
    arrow

    Levetiracetam

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down Click Us! arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2020-06-12

    Pay. Date : 2020-02-20

    DMF Number : 26500

    Submission : 2012-09-27

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2012-324 - Rev 02

    Issue Date : 2024-10-21

    Type : Chemical

    Substance Number : 2535

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 302MF10081

    Registrant's Address : 2nd Floor, Admin Block 27, Vandalooor kelambakkam Road, Keelakottaiyur Village, Melakottaiyur PO, Chennai 600 127 Tamilna

    Initial Date of Registration : 2020-07-09

    Latest Date of Registration :

    EU-WCarrow-down
    ✖

    Date of Issue : 2022-09-30

    Valid Till : 2025-08-04

    Written Confirmation Number : WC-0127

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 72643-025

    Start Marketing Date : 2020-07-16

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Farm & Biz Co., Ltd.

    Registration Date : 2020-07-29

    Registration Number : 20141010-183-I-403-22(2)

    Manufacturer Name : Solara Active Pharma Sciences Limited

    Manufacturer Address : A1/B, Sipcot Industrial Complex, Kudikadu Village Cuddalore-607 005, India

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Oseltamivir Phosphate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Antibody Engineering
    Not Confirmed
    arrow

    Oseltamivir Phosphate

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2015-10-21

    Pay. Date : 2015-09-08

    DMF Number : 22926

    Submission : 2009-07-08

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2015-348 - Rev 02

    Issue Date : 2024-03-28

    Type : Chemical

    Substance Number : 2422

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 305MF10097

    Registrant's Address : No 120 A&B, 36, 120P & 121, Industrial Area, Baikampady, New Mangalore - 575011, Karnataka, India

    Initial Date of Registration : 2023-08-22

    Latest Date of Registration :

    EU-WCInactive-api
    ✖

    Date of Issue : 2021-08-06

    Valid Till : 2024-03-04

    Written Confirmation Number : WC-0294

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 72643-004

    Start Marketing Date : 2011-01-30

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Masung LS Co., Ltd.

    Registration Date : 2020-07-02

    Registration Number : 20190718-209-J-179(5)

    Manufacturer Name : Solara Active Pharma Sciences Limited

    Manufacturer Address : 120 A&B, 120P & 121, Industrial Area Baikampady New Mangalore – 575 011, India

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Aprepitant

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Antibody Engineering
    Not Confirmed
    arrow

    Aprepitant

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 29215

    Submission : 2015-03-27

    Status : Active

    Type : II

     CEP/COS JDMF arrow-down
    ✖

    Registration Number : 305MF10125

    Registrant's Address : 2nd Floor, Admin Block 27, Vandalooor kelambakkam Road, Keelakottaiyur Village, Melakottaiyur PO, Chennai 600 127 Tamilna

    Initial Date of Registration : 2023-11-29

    Latest Date of Registration :

    EU-WCarrow-down
    ✖

    Date of Issue : 2022-09-30

    Valid Till : 2025-08-04

    Written Confirmation Number : WC-0127

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 72643-020

    Start Marketing Date : 2020-02-20

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Bumetanide

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Antibody Engineering
    Not Confirmed
    arrow

    Bumetanide

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2019-04-12

    Pay. Date : 2019-02-11

    DMF Number : 33261

    Submission : 2018-10-27

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2022-034 - Rev 00

    Issue Date : 2024-08-30

    Type : Chemical

    Substance Number : 1076

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2022-09-30

    Valid Till : 2025-08-04

    Written Confirmation Number : WC-0127

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 72643-030

    Start Marketing Date : 2022-11-08

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Celecoxib

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Antibody Engineering
    Not Confirmed
    arrow

    Celecoxib

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2015-01-13

    Pay. Date : 2014-07-03

    DMF Number : 28020

    Submission : 2014-02-19

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2014-222 - Rev 00

    Issue Date : 2021-06-01

    Type : Chemical

    Substance Number : 2591

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2022-09-30

    Valid Till : 2025-08-04

    Written Confirmation Number : WC-0127

    Address of the Firm :

    NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Dextromethorphan Hydrobromide

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Antibody Engineering
    Not Confirmed
    arrow

    Dextromethorphan Hydrobromide

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 26762

    Submission : 2012-12-26

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2013-288 - Rev 00

    Issue Date : 2022-06-28

    Type : Chemical

    Substance Number : 20

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2022-09-30

    Valid Till : 2025-08-04

    Written Confirmation Number : WC-0127

    Address of the Firm :

    NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Dipyridamole

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Antibody Engineering
    Not Confirmed
    arrow

    Dipyridamole

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 35045

    Submission : 2020-08-31

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2021-019 - Rev 00

    Issue Date : 2024-02-27

    Type : Chemical

    Substance Number : 1199

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2022-09-30

    Valid Till : 2025-08-04

    Written Confirmation Number : WC-0127

    Address of the Firm :

    NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Gabapentin

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Antibody Engineering
    Not Confirmed
    arrow

    Gabapentin

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2012-10-26

    Pay. Date : 2012-12-03

    DMF Number : 17543

    Submission : 2004-07-19

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2011-154 - Rev 03

    Issue Date : 2023-09-07

    Type : Chemical

    Substance Number : 2173

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2022-09-30

    Valid Till : 2025-08-04

    Written Confirmation Number : WC-0127

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 72643-014

    Start Marketing Date : 1993-12-30

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Palm East Co., Ltd.

    Registration Date : 2018-07-30

    Registration Number : 20130503-142-I-210-18(13)

    Manufacturer Name : Solara Active Pharma Sciences Limited

    Manufacturer Address : A1/B, Sipcot Industrial Complex, Kudikadu Village Cuddalore-607 005, Tamil Nadu, India

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Nizatidine

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Antibody Engineering
    Not Confirmed
    arrow

    Nizatidine

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 13192

    Submission : 1998-09-21

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2000-083 - Rev 10

    Issue Date : 2023-12-19

    Type : Chemical

    Substance Number : 1453

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2022-09-30

    Valid Till : 2025-08-04

    Written Confirmation Number : WC-0127

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 72643-018

    Start Marketing Date : 1988-04-12

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : EQ Bio Co., Ltd.

    Registration Date : 2023-08-21

    Registration Number : 20130507-144-I-204-04(21)

    Manufacturer Name : Solara Active Pharma Sciences Limited

    Manufacturer Address : A-1/B, Sipcot Industrial Complex Kudikadu Village, Cuddalore - 607 005 Tamilnadu, India

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Olanzapine

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Antibody Engineering
    Not Confirmed
    arrow

    Olanzapine

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2021-07-13

    Pay. Date : 2021-07-09

    DMF Number : 18260

    Submission : 2005-04-08

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2012-050 - Rev 02

    Issue Date : 2023-02-21

    Type : Chemical

    Substance Number : 2258

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2022-09-30

    Valid Till : 2025-08-04

    Written Confirmation Number : WC-0127

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 72643-023

    Start Marketing Date : 2020-05-25

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Pharmasolution Co., Ltd.

    Registration Date : 2024-08-26

    Registration Number : 20210721-209-J-1041(1)

    Manufacturer Name : Solara Active Pharma Sciences Limited

    Manufacturer Address : A1/B, SIPCOT Industrial Complex, Kudikadu, Cuddalore- 607 005, India

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    USDMF

    read-more
    read-more

    01

    Acitretin

    India
    Antibody Engineering
    Not Confirmed
    arrow

    02

    Acyclovir Sodium

    India
    Antibody Engineering
    Not Confirmed
    arrow

    03

    Albendazole

    India
    Antibody Engineering
    Not Confirmed
    arrow

    04

    Aprepitant

    India
    Antibody Engineering
    Not Confirmed
    arrow

    05

    Artemether

    India
    Antibody Engineering
    Not Confirmed
    arrow

    06

    Artesunate

    India
    Antibody Engineering
    Not Confirmed
    arrow

    07

    Atracurium Besylate Usp

    India
    Antibody Engineering
    Not Confirmed
    arrow

    08

    Brivaracetam

    India
    Antibody Engineering
    Not Confirmed
    arrow

    09

    Bumetanide Usp

    India
    Antibody Engineering
    Not Confirmed
    arrow

    10

    Buspirone Hydrochloride Usp

    India
    Antibody Engineering
    Not Confirmed
    arrow
    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Services

    Upload your portfolio for free, ask us

    API Manufacturing

    Click here to discover the service providers for API Manufacturing

    Analytical

    Click here to discover the service providers for Analytical

    API & Drug Product Development

    Click here to discover the service providers for API & Drug Product Development

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Solara Active Pharma Sciences and get a quotation

    Solara Active Pharma Sciences is a supplier offers 124 products (APIs, Excipients or Intermediates).

    Find a price of Levetiracetam bulk with DMF, CEP, JDMF, WC offered by Solara Active Pharma Sciences

    Find a price of Oseltamivir Phosphate bulk with DMF, CEP, JDMF offered by Solara Active Pharma Sciences

    Find a price of Aprepitant bulk with DMF, JDMF, WC offered by Solara Active Pharma Sciences

    Find a price of Bumetanide bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

    Find a price of Celecoxib bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

    Find a price of Dextromethorphan Hydrobromide bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

    Find a price of Dipyridamole bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

    Find a price of Gabapentin bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

    Find a price of Ibuprofen bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

    Find a price of Lanthanum Carbonate bulk with DMF, JDMF, WC offered by Solara Active Pharma Sciences

    Find a price of Mesalazine bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

    Find a price of Nizatidine bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

    Find a price of Olanzapine bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

    Find a price of Venlafaxine Hydrochloride bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

    Find a price of Colchicine bulk with DMF, CEP offered by Solara Active Pharma Sciences

    Find a price of Etomidate bulk with DMF, CEP offered by Solara Active Pharma Sciences

    Find a price of Flecainide bulk with DMF, CEP offered by Solara Active Pharma Sciences

    Find a price of Hydralazine Hydrochloride bulk with DMF, CEP offered by Solara Active Pharma Sciences

    Find a price of Mesna bulk with DMF, CEP offered by Solara Active Pharma Sciences

    Find a price of Ranitidine Hydrochloride bulk with CEP, WC offered by Solara Active Pharma Sciences

    Find a price of Succinylcholine Chloride bulk with DMF, CEP offered by Solara Active Pharma Sciences

    Find a price of Sulfiram bulk with DMF, CEP offered by Solara Active Pharma Sciences

    Find a price of Brivaracetam bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Buspirone Hydrochloride bulk with DMF, CEP offered by Solara Active Pharma Sciences

    Find a price of Carisoprodol bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Cetirizine Dihydrochloride bulk with DMF, CEP offered by Solara Active Pharma Sciences

    Find a price of Cinacalcet Hydrochloride bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Colesevelam Hydrochloride bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Cycloserine bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Ethacrynic Acid bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Ibuprofen bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Ibuprofen Lysinate bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Ibuprofen Sodium bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Isradipine bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Ketoprofen bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Lurasidone Hydrochloride bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Mefenamic Acid bulk with DMF, CEP offered by Solara Active Pharma Sciences

    Find a price of Meprobamate bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Methohexital bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Mirabegron bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Mycophenolate Mofetil bulk with DMF, CEP offered by Solara Active Pharma Sciences

    Find a price of Mycophenolate Sodium bulk with DMF, CEP offered by Solara Active Pharma Sciences

    Find a price of Obeticholic Acid bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Pitavastatin bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Posaconazole bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Pregabalin bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Rotigotine bulk with DMF, JDMF offered by Solara Active Pharma Sciences

    Find a price of Safinamide Mesylate bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Sevelamer Carbonate bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Sevelamer Hydrochloride bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Tenofovir Disoproxil Fumarate bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Zileuton bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Imiquimod bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Methoxsalen bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Praziquantel bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Quinapril bulk with WC offered by Solara Active Pharma Sciences

    Find a price of Ranitidine bulk with WC offered by Solara Active Pharma Sciences

    Find a price of Rifaximin bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Acitretin bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Acyclovir Sodium bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Albendazole bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Artemether bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Artesunate bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Atracurium Besylate bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Chlorphenesin bulk with WC offered by Solara Active Pharma Sciences

    Find a price of Chlorpromazine Hydrochloride bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Chlorthalidone bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Clomipramine Hydrochloride bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Colestipol bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Dabigatran Etexilate Mesylate bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Dextromethorphan bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Edaravone bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Efinaconazole bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Ertapenem Sodium bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Erythromycin Ethyl Succinate bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Felbamate bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Fluocytosine bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Ibuprofen bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Ibuprofen Lysinate bulk with WC offered by Solara Active Pharma Sciences

    Find a price of Ibuprofen Sodium bulk with WC offered by Solara Active Pharma Sciences

    Find a price of Indomethacin Sodium bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Iron Sucrose bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Labetalol Hydrochloride bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Lacidipine bulk with WC offered by Solara Active Pharma Sciences

    Find a price of Lanthanum Carbonate bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Loratadine bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Lumefantrine bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Mebendazole bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Midazolam bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Milnacipran Hydrochloride bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Nabumetone bulk with WC offered by Solara Active Pharma Sciences

    Find a price of Naproxen bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Naproxen Sodium bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Pantoprazole Sodium bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Patiromer Sorbitex Calcium bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Pentoxifylline bulk with CEP offered by Solara Active Pharma Sciences

    Find a price of Sapropterin Hydrochloride bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Sodium Zirconium Cyclosilicate bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Sugammadex Sodium bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Tioconazole bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Ursodeoxycholic Acid bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Venlafaxine Hydrochloride bulk with CEP offered by Solara Active Pharma Sciences

    Find a price of Zidovudine bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Citicoline Sodium bulk offered by Solara Active Pharma Sciences

    Find a price of Colchicine bulk offered by Solara Active Pharma Sciences

    Find a price of Etomidate bulk offered by Solara Active Pharma Sciences

    Find a price of Flecainide bulk offered by Solara Active Pharma Sciences

    Find a price of Mesna bulk offered by Solara Active Pharma Sciences

    Find a price of Methoxsalen bulk offered by Solara Active Pharma Sciences

    Find a price of Naproxen bulk offered by Solara Active Pharma Sciences

    Find a price of Naproxen Sodium bulk offered by Solara Active Pharma Sciences

    Find a price of Ranitidine Hydrochloride bulk offered by Solara Active Pharma Sciences

    Find a price of Rifaximin bulk offered by Solara Active Pharma Sciences

    Find a price of Sulfasalazine bulk offered by Solara Active Pharma Sciences

    Find a price of Sulfiram bulk offered by Solara Active Pharma Sciences

    Find a price of Carbidopa bulk offered by Solara Active Pharma Sciences

    Find a price of Choline Chloride bulk offered by Solara Active Pharma Sciences

    Find a price of Edoxaban Tosylate bulk offered by Solara Active Pharma Sciences

    Find a price of Etilevodopa bulk offered by Solara Active Pharma Sciences

    Find a price of Favipiravir bulk offered by Solara Active Pharma Sciences

    Find a price of Migalastat bulk offered by Solara Active Pharma Sciences

    Find a price of Patiromer bulk offered by Solara Active Pharma Sciences

    Find a price of Sertraline Hydrochloride bulk offered by Solara Active Pharma Sciences

    Find a price of Tranexamic Acid bulk offered by Solara Active Pharma Sciences

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search